SE419500B - PROCEDURE FOR ATTENUATION OF A CORONA VIRUS-LIKE CALVDAR REVIRUS FOR PREPARATION OF CALV DIARVACCIN - Google Patents

PROCEDURE FOR ATTENUATION OF A CORONA VIRUS-LIKE CALVDAR REVIRUS FOR PREPARATION OF CALV DIARVACCIN

Info

Publication number
SE419500B
SE419500B SE7314001A SE7314001A SE419500B SE 419500 B SE419500 B SE 419500B SE 7314001 A SE7314001 A SE 7314001A SE 7314001 A SE7314001 A SE 7314001A SE 419500 B SE419500 B SE 419500B
Authority
SE
Sweden
Prior art keywords
revirus
diarvaccin
calvdar
calv
attenuation
Prior art date
Application number
SE7314001A
Other languages
Swedish (sv)
Inventor
C A Mebus
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Publication of SE419500B publication Critical patent/SE419500B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7314001A 1972-10-30 1973-10-16 PROCEDURE FOR ATTENUATION OF A CORONA VIRUS-LIKE CALVDAR REVIRUS FOR PREPARATION OF CALV DIARVACCIN SE419500B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (1)

Publication Number Publication Date
SE419500B true SE419500B (en) 1981-08-10

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7314001A SE419500B (en) 1972-10-30 1973-10-16 PROCEDURE FOR ATTENUATION OF A CORONA VIRUS-LIKE CALVDAR REVIRUS FOR PREPARATION OF CALV DIARVACCIN

Country Status (17)

Country Link
JP (3) JPS5817169B2 (en)
AR (1) AR200155A1 (en)
AU (1) AU476160B2 (en)
BE (1) BE806568A (en)
CA (1) CA1019675A (en)
CH (1) CH596315A5 (en)
DD (1) DD110517A5 (en)
DE (1) DE2354324C2 (en)
ES (1) ES419996A1 (en)
FI (1) FI52740C (en)
FR (1) FR2204405B1 (en)
GB (1) GB1401565A (en)
HU (1) HU168486B (en)
IE (1) IE38423B1 (en)
NL (1) NL7314293A (en)
SE (1) SE419500B (en)
ZA (1) ZA738329B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (en) * 1983-07-30 1985-02-23 株式会社 協立双葉自動機 Labeling machine with container rotation speed adjustment device
JPH0518338Y2 (en) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
JPH08786B2 (en) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 Bovine coronavirus infectious disease vaccine
US10808227B2 (en) 2015-11-06 2020-10-20 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (en) * 1969-11-28 1971-05-25 Mebus Charles A CALVES DIARRHEA VACCINES, THEIR PREPARATION AND USE
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
ZA738329B (en) 1974-09-25
FR2204405B1 (en) 1977-01-28
IE38423B1 (en) 1978-03-15
JPS5531058A (en) 1980-03-05
JPS6124370B2 (en) 1986-06-10
IE38423L (en) 1974-04-30
DD110517A5 (en) 1974-12-20
BE806568A (en) 1974-04-26
AU6177473A (en) 1975-04-24
JPS4980230A (en) 1974-08-02
FR2204405A1 (en) 1974-05-24
DE2354324C2 (en) 1982-06-03
NL7314293A (en) 1974-05-02
JPS5817169B2 (en) 1983-04-05
GB1401565A (en) 1975-07-16
ES419996A1 (en) 1976-08-01
JPS57131726A (en) 1982-08-14
CH596315A5 (en) 1978-03-15
FI52740C (en) 1977-11-10
AU476160B2 (en) 1976-09-16
JPS5757449B2 (en) 1982-12-04
HU168486B (en) 1976-05-28
CA1019675A (en) 1977-10-25
FI52740B (en) 1977-08-01
DE2354324A1 (en) 1974-05-09
AR200155A1 (en) 1974-10-24

Similar Documents

Publication Publication Date Title
NO783636L (en) PROCEDURE FOR PREPARATION OF N-PHOSPHONOMETHYL-GLYCIN
FI65459B (en) FRAMEWORK FOR THE FRAMEWORK OF FIXED FIBERS
NO140731C (en) PROCEDURE FOR THE PREPARATION OF DIMETHYLETER
SE7604260L (en) PROCEDURE FOR ISOLATION OF AP-GLYCOPROTEINS
SE399064B (en) PROCEDURE FOR THE PREPARATION OF A NEW DOPAMINE DERIVATIVE
SE395149B (en) PROCEDURE FOR THE PREPARATION OF DIBENSO-TIEPINYLPIPERAZINE DERIVATIVES
SE386892B (en) PROCEDURE FOR THE PREPARATION OF OXAMINO COMPOUNDS
NO140478C (en) PROCEDURE FOR MANUFACTURE OF FIBRILLS
SE401676B (en) PROCEDURE FOR THE PREPARATION OF DIBENSOFURAN DERIVATIVES
SE382053B (en) PROCEDURE FOR THE PREPARATION OF BIFENYLYL ALKANOYLAMINOPYRIDINES
SE432691B (en) PROCEDURE FOR THE PREPARATION OF A FISH PROTEIN ISOLATE
SE419500B (en) PROCEDURE FOR ATTENUATION OF A CORONA VIRUS-LIKE CALVDAR REVIRUS FOR PREPARATION OF CALV DIARVACCIN
SE381397B (en) PROCEDURE FOR THE PREPARATION OF AN AROMATING AGENT
IT1002359B (en) METHOD OF PREPARATION OF ALCYLATES
SE399425B (en) PROCEDURE FOR PREPARATION OF 1-PHENOXI-3-AMINOPROPAN-2-OL DERIVATIVES
SE383151B (en) PROCEDURE FOR THE PREPARATION OF 1-HYDROXY-2-PYRIDONES
SE393111B (en) PROCEDURE FOR THE PREPARATION OF D-2-HALOGEN-6-METHYL-8-SUBSTITUTED - ERGOLINE
SE380272B (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONE METHYLLYCINE
FI56830B (en) PROCEDURE FOR THE PREPARATION OF ASPARAGINYLGRUPPER INNEHAOLLANDE BIOLOGISKT AKTIVA POLYPEPTIDER
SE415355B (en) PROCEDURE FOR THE PREPARATION OF PHOSPHONOTIOUREIDS
SE393808B (en) PROCEDURE FOR THE PREPARATION OF ISOMALTITE
FI56670B (en) PROCEDURE FOR FRAMSTATION OF AV 5-CYCLOHEXYL-6-HALOGENINDAN-1-CARBOXYLSYRADERIVAT
SE416952B (en) METHOD OF PREPARING SUBSTITUTED PHENYLAMIDINOCARBAMIDE COMPOUNDS
SE422273B (en) PROCEDURE FOR THE PREPARATION OF A MINERAL SALT PREPARATION
SE380805B (en) PROCEDURE FOR THE PREPARATION OF OXAZOLES